Company intelligence / Profile preview

Ayrton Capital

Westport, Connecticut, United Statesayrtonllc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Ayrton Capital is an absolute-return focused investment firm founded in 2016 by Waqas Khatri. The firm combines fundamental research and quantitative analysis to identify attractive investment opportunities across asset classes and geographies. While sector-agnostic, it has notable expertise and portfolio exposure in healthcare, biotechnology, specialty pharmaceuticals, and medical devices through its investments. It does not conduct clinical trials or have its own drug pipeline.

Industry: Investors

Beyond the preview

Go deeper on Ayrton Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ayrton Capital.

Explore the full profile